基于“肺合大肠”探讨升降散治疗支气管哮喘

Treatment of Bronchial Asthma with Shengjiang Powder Based on"Lung and Large Intestine in Pair"

支气管哮喘是呼吸系统常见的慢性疾病,基于“肺合大肠”理论,升降散通过调肺气、通腑气,肺肠同治,在防治支气管哮喘上取得了一定成效。现代医学的“肺肠轴”理论认为,以肺肠菌群为基础,通过菌群及其代谢产物的作用,参与黏膜免疫,证明了肺肠在生理及病理上存在相互联系,与“肺合大肠”理论不谋而合,赋予了“肺合大肠”理论现代科学含义。故通过分析“肺合大肠”理论的中西医内涵,探讨升降散治疗支气管哮喘的理论依据及应用,以期为中医临床防治支气管哮喘提供新思路。

Bronchial asthma is a common chronic disease of the respiratory system.According to the theory of"lung and large intestine in pair",Shengjiang Powder can regulate the qi movement in the lung qi and fu organs to simultaneously treat the lung and large intestine,achieving the prevention and treatment of bronchial asthma.According to the modern medical theory of lung-gut axis,the intestinal flora and its metabolites participate in mucosal immunity,which proves that the lung and intestine are physiologically and pathologically interconnected,coinciding with the theory of"lung and large intestine in pair"and provides a modern medical explanation to this theory.This paper analyzed the connotation of the theory of lung and large intestine in pair in traditional Chinese and Western medicine and discussed the theoretical basis and application of Shengjiang Powder in the treatment of bronchial asthma,aiming to provide new ideas for the clinical prevention and treatment of bronchial asthma with traditional Chinese medicine.